Peak6 Investments LLC Sage Therapeutics, Inc. Put Options Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $251,250 - $734,700	15,000 New	15,000 $308,000
Q1 2020 May 14, 2020	SELL	$26.15 - $77.24 $104,600 - $308,960	-4,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $81,940 - $139,710	1,000 Added 33.33%	4,000 $383,000
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $414,330 - $507,120	3,000 New	3,000 $424,000

218

46.4M

847K

188K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.